Live Breaking News & Updates on Charnwood Molecular

Charnwood Molecular Unveils Significant Expansion Plans
Search jobs
Charnwood Molecular Unveils Significant Expansion Plans
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, has unveiled plans for significant expansion in 2021.
Charnwood Molecular continues to build upon its foundation in medicinal chemistry, scale-up chemistry and custom synthesis provision, evolving its business strategy to deliver increasingly high-tech and high-value research capabilities. In order to enable and enhance its ambitious expansion plans, Charnwood Molecular recently partnered with Synova, a leading and award-winning European private equity fund, who have made a significant investment into the business. The deal has provided the company with additional capital to support its future development and growth, including the introduction of additional senior leadership team members int ....

Gosia Khrais , Steve Allin , John Handley , Life Sciences Opportunity Zone , Charnwood Molecular , United Kingdom Based , Charnwood Campus , Managing Director , Marketing Director , ஜான் ஹேண்ட்லி , வாழ்க்கை அறிவியல் வாய்ப்பு ஸோந் , சார்ன்வுட் மூலக்கூறு , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது , சார்ன்வுட் வளாகம் , நிர்வகித்தல் இயக்குனர் , சந்தைப்படுத்தல் இயக்குனர் ,